Results 11 to 20 of about 13,204 (176)
(Abstracted from N Engl J Med 2016;375:2468–2479) Neonatal abstinence syndrome (NAS) is a postnatal opioid withdrawal syndrome occurring in 55% to 94% of newborns whose mothers were addicted to or treated with opioids while pregnant. A lack of clarity and consistency regarding the definition, measurement, and management of the syndrome still ...
Karen, McQueen, Jodie, Murphy-Oikonen
exaly +10 more sources
Neonatal abstinence syndrome. [PDF]
A 12 month review of infants admitted with neonatal abstinence syndrome to a neonatal intensive care unit was undertaken. The relationship of maternal drug abuse to symptoms, the effectiveness of pharmacologic agents in controlling symptoms and the ...
Beckett, M +6 more
core +2 more sources
Editorial: The neurology and neurobiology of neonatal abstinence syndrome [PDF]
Kelly J. Clemens +2 more
doaj +2 more sources
Neonatal Abstinence Syndrome [PDF]
Opioid use and abuse have skyrocketed in the United States over the last decade. As a result, we have seen a substantial increase in neonates who are exposed to opioids in-utero. Anywhere from 55% to 94% of infants exposed to opioids will experience withdrawal, known as neonatal abstinence syndrome (NAS), and will require management of ...
Kristina M. Reber +3 more
+6 more sources
Neonatal Abstinence Syndrome [PDF]
Neonatal Abstinence Syndrome (NAS) occurs in infants exposed to opiates or illicit drugs during pregnancy. It can be severe and cause long hospital stays after birth and with symptoms up to 6 months after birth. Pharmacologic interventions are commonly used as treatment for NAS; however, their safety and efficacy are not fully recognized. Pharmacologic
Iliana Bersani +6 more
+8 more sources
Intrauterine exposure to drugs by mothers is not an uncommon finding ine our society. Due to the mother’s suppression of a medical history, the diagnosis of neonatal abstinence syndrome is often missed. We report a case of a term, female, newborn, who presented with the following features;e restlessness, inconsolable crying, along with sweating ...
K K, Mishra +5 more
+8 more sources
Nursing professionals’ knowledge in the management of newborns with neonatal abstinence syndrome
OBJECTIVE: To identify the knowledge of nursing professionals about drug use in pregnant and postpartum women and the management of newborns with neonatal abstinence syndrome. METHOD: Quantitative, cross-sectional and descriptive field research, composed
Laís Lima Silva +1 more
doaj +1 more source
This review examines the continuum of care of opioid-exposed infants, including the assessment of the neonate, diagnosis of neonatal abstinence syndrome, management of the syndrome including nonpharmacologic and pharmacologic care, approach to breastfeeding, pediatric follow-up care, and integration of care of the mother-infant dyad.
Lauren M, Jansson, Stephen W, Patrick
+8 more sources
Nursing interventions and assessment tool for neonatal abstinence syndrome (NAS): a case report
A newborn female was admitted to the Neonatal Intensive Care Unit 2 days after birth with neonatal abstinence syndrome (NAS). The patient displayed withdrawal symptoms from substance misuse, which was passively absorbed in utero via the placenta.
Lorenzo Righi +4 more
doaj +1 more source
There is variation in cardiorespiratory monitoring practices for neonatal abstinence syndrome. We examined the incidence of cardiorespiratory adverse events in infants with neonatal abstinence syndrome who were treated or nontreated pharmacologically ...
Spoorthi Davala, BA +5 more
doaj +1 more source

